Name | (9Z)-N-[(2R)-1-Hydroxy-3-(4-hydroxyphenyl)-2-propanyl]-9-octadecenamide |
---|---|
Synonyms |
(9Z)-N-[(2R)-1-Hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide
9-Octadecenamide, N-[(1R)-2-hydroxy-1-[(4-hydroxyphenyl)methyl]ethyl]-, (9Z)- (9Z)-N-[(2R)-1-Hydroxy-3-(4-hydroxyphenyl)-2-propanyl]-9-octadecenamide |
Description | OMDM-2 is a potent, selective and metabolically stable inhibitor of anandamide cellular uptake (ACU), with a Ki of 3.0 μM[1]. |
---|---|
Related Catalog | |
Target |
Ki: 3.0 μM (anandamide cellular uptake)[1] |
In Vitro | OMDM-2 shows poor affinity for either CB1 (Ki=5.1 μM) or CB2 (Ki>10 μM) receptors in rat brain and spleen membranes, respectively; OMDM-2 has almost no activity at vanilloid receptors in the intracellular calcium assay carried out with intact cells over-expressing the human VR1 (EC50=10 μM), and no activity as inhibitors of FAAH in N18TG2 cell membranes (Ki>50 μM)[1]. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 625.8±55.0 °C at 760 mmHg |
Molecular Formula | C27H45NO3 |
Molecular Weight | 431.651 |
Flash Point | 332.3±31.5 °C |
Exact Mass | 431.339935 |
LogP | 7.76 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.518 |